By expenditures
| Name | Title | Type |
|---|---|---|
| Fermin Ramirez | Audit Partner | Auditee |
| Teresa Montemayor | Chief Financial Officer | Auditee |
| Kacey Gast | Audit Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 384188 | 2025 | 2026-01-29 | BOLINGER SEGARS GILBERT & MOSS LLP | $3.81M |
| 338982 | 2024 | 2025-01-21 | Bolinger Segars Gilbert & Moss LLP | $6.65M |
| 13588 | 2023 | 2024-01-25 | Bolinger Segars Gilbert & Moss LLP | $8.91M |
| 25831 | 2022 | 2023-02-13 | Cmms CPAS & Advisors PLLC | $9.91M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 384188 | 2025 | 2026-01-29 | 1170902 | 2025-001 | Material Weakness | Yes | E |
| 384188 | 2025 | 2026-01-29 | 1170901 | 2025-001 | Material Weakness | Yes | E |
| 384188 | 2025 | 2026-01-29 | 1170900 | 2025-001 | Material Weakness | Yes | E |
| 384188 | 2025 | 2026-01-29 | 1170899 | 2025-001 | Material Weakness | Yes | E |
| 384188 | 2025 | 2026-01-29 | 1170898 | 2025-001 | Material Weakness | Yes | E |
| 338982 | 2024 | 2025-01-21 | 1096237 | 2024-001 | Significant Deficiency | - | E |
| 338982 | 2024 | 2025-01-21 | 1096236 | 2024-001 | Significant Deficiency | - | E |
| 338982 | 2024 | 2025-01-21 | 1096235 | 2024-001 | Significant Deficiency | - | E |
| 338982 | 2024 | 2025-01-21 | 1096234 | 2024-001 | Significant Deficiency | - | E |
| 338982 | 2024 | 2025-01-21 | 1096233 | 2024-001 | Significant Deficiency | - | E |
| 338982 | 2024 | 2025-01-21 | 1096232 | 2024-001 | Significant Deficiency | - | E |
| 338982 | 2024 | 2025-01-21 | 519795 | 2024-001 | Significant Deficiency | - | E |
| 338982 | 2024 | 2025-01-21 | 519794 | 2024-001 | Significant Deficiency | - | E |
| 338982 | 2024 | 2025-01-21 | 519793 | 2024-001 | Significant Deficiency | - | E |
| 338982 | 2024 | 2025-01-21 | 519792 | 2024-001 | Significant Deficiency | - | E |
| 338982 | 2024 | 2025-01-21 | 519791 | 2024-001 | Significant Deficiency | - | E |
| 338982 | 2024 | 2025-01-21 | 519790 | 2024-001 | Significant Deficiency | - | E |